2022
DOI: 10.1007/s00408-022-00567-6
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 45 publications
3
16
0
Order By: Relevance
“…For geriatric COPD patients, GNRI may be useful to be applied as a nutritional assessment scale ( 28 , 29 ). As regard to malignancy, two meta-analyses concluded that low GNRI level was correlated with poor overall survival in patients with gastrointestinal malignancy ( 30 ) and lung cancer ( 31 ). Other studies also found its prognostic value in hepatocellular carcinoma ( 32 ), renal cancer ( 33 ), bladder cancer ( 34 ), and lymphoma ( 35 , 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…For geriatric COPD patients, GNRI may be useful to be applied as a nutritional assessment scale ( 28 , 29 ). As regard to malignancy, two meta-analyses concluded that low GNRI level was correlated with poor overall survival in patients with gastrointestinal malignancy ( 30 ) and lung cancer ( 31 ). Other studies also found its prognostic value in hepatocellular carcinoma ( 32 ), renal cancer ( 33 ), bladder cancer ( 34 ), and lymphoma ( 35 , 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…While sufficient research linking GNRI and outcomes of BC is not available in the literature, there have been numerous studies showing GNRI to be an independent prognostic indicator in cancer patients. Reviews have confirmed the prognostic ability of GNRI for non-small cell lung cancer [10], esophageal cancer [37], and colorectal cancer [9].…”
Section: Discussionmentioning
confidence: 99%
“…It has been used to assess malnutritional risk in hospitalized adults over 65 years. Multiple studies have reported its prognostic impact in several cancer types, including HNSCC, independent of patient age [ 11 , 12 , 13 ]. Recently, Nakayama et al reported a prognostic effect of the GNRI for overall survival in patients with advanced head and neck cancer at all ages [ 14 ].…”
Section: Introductionmentioning
confidence: 99%